Kusajili – Clinical trials directory

Result of your search per sponsor: Manmeet Ahluwalia, MD, FACP

Woman and Man Max 99 years
Manmeet Ahluwalia, MD, FACP Update Il y a 5 ans

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma This phase II trial will investigate the efficacy and safety of the addition of Optune (Tumor Treating Fields or TTF Therapy) to bevacizumab for patients with bevacizumab-refractory recurr...

Country None
organs None
Specialty None

Opened trial

More information